Send Email

Working Hours

Mon-Fri 08:00AM - 06:00PM

Need Any Help?


Product Detail

  • Lorlatinib
  • Lorlatinib
  • Lorlatinib
  • Lorlatinib


  • CAS No.1454846-35-5:
  • Molecular Formula:C21H19FN6O2:
  • Molecular Weight:406.4:
  • Purity:NLT 99.5:
  • Reference Standard:In-house:
  • Documentation:China DMF:
  • Inqury

Product Description

Lorlatinib is a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) indicated for the treatment of patients with ALK-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on a) the prior use of crizotinib and at least one other ALK inhibitor for metastatic disease, or b) the prior use of alectinib as the first ALK inhibitor therapy for metastatic disease, or c) the prior use of certinib as the first ALK inhibitor therapy for metastatic disease.

Hits: 【Print】 
None Brigatinib